Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LIFECORE BIOMEDICAL, INC. \DE\LNDC · Entity 6447 | Director | May 30, 2018 | June 01, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LIFECORE BIOMEDICAL, INC. \DE\
Report date May 30, 2018 · Filed June 01, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Right to Buy Restricted Stock Unit (RSU)SEC Table II · derivative / convertible security | IndirectHeld in Trust | 4,240 |
Reported balance
After 2018-05-30 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2018-05-30 · Exercise / conversion · Acquired 4,240 · Balance 4,240 F1: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2: Restricted Stock Units will vest in 4.5 months from the grant date and will be automatically settled in shares of common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis.
F2: Restricted Stock Units will vest in 4.5 months from the grant date and will be automatically settled in shares of common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 30, 2018 Filed Jun 1, 2018 21:35 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRight to Buy Restricted Stock Unit (RSU) · Derivative | 4,240 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-18-011096 · rdgdoc.xml · derivative · entry 1 STEELE GARY T · CIK 0001192863 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held in Trust Disclosed balance after: 4,240 Underlying: Common Stock · 4,240 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · derivative.expiration_date: Restricted Stock Units will vest in 4.5 months from the grant date and will be automatically settled in shares of common stock. Read SEC document |
| May 23, 2018 Filed May 25, 2018 21:37 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRestricted Stock Unit · Derivative | 4,286 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-010769 · rdgdoc.xml · derivative · entry 4 STEELE GARY T · CIK 0001192863 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held In Trust Disclosed balance after: 0 Underlying: Common Stock · 4,286 shares Expires 2018-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · shares: The restricted stock units were granted on June 1, 2017. F3 · derivative.exercise_date: The restricted stock units vested on May 23, 2018. Read SEC document |
| May 23, 2018 Filed May 25, 2018 21:37 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRestricted Stock Unit · Derivative | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-010769 · rdgdoc.xml · derivative · entry 3 STEELE GARY T · CIK 0001192863 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held In Trust Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2018-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F4 · shares: The restricted stock units were granted on May 28, 2015. F3 · derivative.exercise_date: The restricted stock units vested on May 23, 2018. Read SEC document |
| May 23, 2018 Filed May 25, 2018 21:37 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionCommon Stock | 4,286 | $13.65 | $58,503.90 |
DisclosureSEC source: 0001437749-18-010769 · rdgdoc.xml · nonDerivative · entry 2 STEELE GARY T · CIK 0001192863 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held in Trust Disclosed balance after: 112,402 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. Read SEC document |
| May 23, 2018 Filed May 25, 2018 21:37 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionCommon Stock | 20,000 | $13.65 | $273,000.00 |
DisclosureSEC source: 0001437749-18-010769 · rdgdoc.xml · nonDerivative · entry 1 STEELE GARY T · CIK 0001192863 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held in Trust Disclosed balance after: 108,116 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. Read SEC document |
| May 01, 2018 Filed May 30, 2018 19:59 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | GiftCommon Stock | 9,326 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-010917 · rdgdoc.xml · nonDerivative · entry 1 STEELE GARY T · CIK 0001192863 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held in Trust Disclosed balance after: 103,076 Read SEC document |
| June 01, 2017 Filed Jun 5, 2017 23:32 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRight to Buy Restricted Stock Unit (RSU) · Derivative | 4,286 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-17-010675 · rdgdoc.xml · derivative · entry 1 STEELE GARY T · CIK 0001192863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,286 Underlying: Common Stock · 4,286 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · derivative.expiration_date: Restricted Stock Units will vest on the 1st anniversary of the grant date and will be automatically settled in shares of common stock. Read SEC document |
| May 25, 2017 Filed May 26, 2017 23:06 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRestricted Stock Units · Derivative | 5,282 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-17-010194 · rdgdoc.xml · derivative · entry 2 STEELE GARY T · CIK 0001192863 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held in Trust Disclosed balance after: 0 Underlying: Common Stock · 5,282 shares Expires 2017-05-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · shares: The restricted stock units were granted on May 25, 2016. F3 · derivative.exercise_date: The restricted stock units vested on May 25, 2017. F3 · derivative.expiration_date: The restricted stock units vested on May 25, 2017. Read SEC document |
| May 25, 2017 Filed May 26, 2017 23:06 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionCommon Stock | 5,282 | $13.50 | $71,307.00 |
DisclosureSEC source: 0001437749-17-010194 · rdgdoc.xml · nonDerivative · entry 1 STEELE GARY T · CIK 0001192863 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Trust Disclosed balance after: 88,116 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. Read SEC document |
| May 10, 2017 Filed May 10, 2017 20:26 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | SaleCommon Stock | 26,708 | $14.00 | $373,912.00 |
DisclosureSEC source: 0001437749-17-008624 · rdgdoc.xml · nonDerivative · entry 5 STEELE GARY T · CIK 0001192863 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held in Trust Disclosed balance after: 82,834 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.85 to $14, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 10, 2017 Filed May 10, 2017 20:26 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | SaleCommon Stock | 26,708 | $14.00 | $373,912.00 |
DisclosureSEC source: 0001437749-17-008625 · rdgdoc.xml · nonDerivative · entry 5 STEELE GARY T · CIK 0001192863 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held in Trust Disclosed balance after: 82,834 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.85 to $14, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 08, 2017 Filed May 10, 2017 20:26 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | OtherNonqualified Stock Options (Right to Buy) · Derivative | 44,672 | $5.63 Strike: $14.00 | $251,503.36 |
DisclosureSEC source: 0001437749-17-008624 · rdgdoc.xml · derivative · entry 7 STEELE GARY T · CIK 0001192863 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held in Trust Disclosed balance after: 105,000 Underlying: Common Stock · 44,672 shares Expires 2017-05-26 Read SEC document |
| May 08, 2017 Filed May 10, 2017 20:26 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | OtherIncentive Stock Option (Right to Buy) · Derivative | 30,328 | $5.63 Strike: $14.00 | $170,746.64 |
DisclosureSEC source: 0001437749-17-008624 · rdgdoc.xml · derivative · entry 6 STEELE GARY T · CIK 0001192863 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held in Trust Disclosed balance after: 149,672 Underlying: Common Stock · 30,328 shares Expires 2017-05-26 Read SEC document |
| May 08, 2017 Filed May 10, 2017 20:26 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Tax withholdingCommon Stock | 17,964 | $14.00 | $251,496.00 |
DisclosureSEC source: 0001437749-17-008624 · rdgdoc.xml · nonDerivative · entry 4 STEELE GARY T · CIK 0001192863 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held In Trust Disclosed balance after: 109,542 Read SEC document |
| May 08, 2017 Filed May 10, 2017 20:26 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionCommon Stock | 44,672 | $5.63 | $251,503.36 |
DisclosureSEC source: 0001437749-17-008624 · rdgdoc.xml · nonDerivative · entry 3 STEELE GARY T · CIK 0001192863 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held in Trust Disclosed balance after: 127,506 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 08, 2017 Filed May 10, 2017 20:26 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Tax withholdingCommon Stock | 12,196 | $14.00 | $170,744.00 |
DisclosureSEC source: 0001437749-17-008624 · rdgdoc.xml · nonDerivative · entry 2 STEELE GARY T · CIK 0001192863 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held In Trust Disclosed balance after: 82,834 Read SEC document |
| May 08, 2017 Filed May 10, 2017 20:26 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionCommon Stock | 30,328 | $5.63 | $170,746.64 |
DisclosureSEC source: 0001437749-17-008624 · rdgdoc.xml · nonDerivative · entry 1 STEELE GARY T · CIK 0001192863 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held in Trust Disclosed balance after: 95,030 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 08, 2017 Filed May 10, 2017 20:26 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | OtherNonqualified Stock Options (Right to Buy) · Derivative | 44,672 | $5.63 Strike: $14.00 | $251,503.36 |
DisclosureSEC source: 0001437749-17-008625 · rdgdoc.xml · derivative · entry 7 STEELE GARY T · CIK 0001192863 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held in Trust Disclosed balance after: 105,000 Underlying: Common Stock · 44,672 shares Expires 2017-05-26 Read SEC document |
| May 08, 2017 Filed May 10, 2017 20:26 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | OtherIncentive Stock Option (Right to Buy) · Derivative | 30,328 | $5.63 Strike: $14.00 | $170,746.64 |
DisclosureSEC source: 0001437749-17-008625 · rdgdoc.xml · derivative · entry 6 STEELE GARY T · CIK 0001192863 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held in Trust Disclosed balance after: 149,672 Underlying: Common Stock · 30,328 shares Expires 2017-05-26 Read SEC document |
| May 08, 2017 Filed May 10, 2017 20:26 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Tax withholdingCommon Stock | 17,964 | $14.00 | $251,496.00 |
DisclosureSEC source: 0001437749-17-008625 · rdgdoc.xml · nonDerivative · entry 4 STEELE GARY T · CIK 0001192863 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held In Trust Disclosed balance after: 109,542 Read SEC document |
| May 08, 2017 Filed May 10, 2017 20:26 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionCommon Stock | 44,672 | $5.63 | $251,503.36 |
DisclosureSEC source: 0001437749-17-008625 · rdgdoc.xml · nonDerivative · entry 3 STEELE GARY T · CIK 0001192863 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held in Trust Disclosed balance after: 127,506 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 08, 2017 Filed May 10, 2017 20:26 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Tax withholdingCommon Stock | 12,196 | $14.00 | $170,744.00 |
DisclosureSEC source: 0001437749-17-008625 · rdgdoc.xml · nonDerivative · entry 2 STEELE GARY T · CIK 0001192863 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held In Trust Disclosed balance after: 82,834 Read SEC document |
| May 08, 2017 Filed May 10, 2017 20:26 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionCommon Stock | 30,328 | $5.63 | $170,746.64 |
DisclosureSEC source: 0001437749-17-008625 · rdgdoc.xml · nonDerivative · entry 1 STEELE GARY T · CIK 0001192863 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held in Trust Disclosed balance after: 95,030 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.